Beware the quantum computers
Today’s encryption technology will be putty in the hands of those running the post-quantum world. How equipped ...
Syngene International Ltd, a global contract research organisation, has commissioned the first phase of its new R&D centre in Genome Valley, Hyderabad.
The facility is spread across 52,000 sq. ft. with an initial strength of around 150 scientists. This is the company’s first operational research centre outside Bengaluru. When fully commissioned by the end of this year, at an investment of ₹167 crore, it will cover a total of 94,000 sq. ft. and house 270 scientists.
After inaugurating the centre, KT Rama Rao, Telangana Industries and IT Minister, said, “The Syngene has selected Telangana for setting up its new R&D centre. This is a testimony to one of the accomplishments of BioAsia which has been able to showcase the immense potential, opportunity, and support the state offers.”
“We have been focusing on the Life Sciences sector and the Genome Valley was conceptualised to provide all the necessary infrastructure and support systems for life science R&D activities. Syngene’s presence is surely a boost for the state’s vision to be a biotech hub,” he said.
Kiran Mazumdar Shaw, Managing Director, Syngene said, “We are delighted to set up our new R&D centre in Genome Valley, Telangana, recognised as a leading global biotech hub.”
Jonathan Hunt, Chief Executive Officer, Syngene, said, “The inauguration of this site in Genome Valley today marks an important step for the company. With increasing demand for our research services, we needed to find a location that offered the right environment to drive scientific innovation and seamless delivery.”
Genome Valley is India’s first purpose-built cluster for life sciences R&D activities spread across 600 sq km. Syngene’s new R&D centre is located in MN Park at the heart of the Genome Valley.
Initially, the company will offer Discovery Chemistry services from Hyderabad. In the next phase, other research services will move to the centre providing research to the world’s leading pharmaceutical companies.
Syngene currently operates through multiple facilities in Bengaluru spread across an area of 1.5 million sq ft. comprising research and manufacturing facilities. These facilities have successfully cleared multiple global regulatory inspections, including the USFDA, EMA and PMDA.
Today’s encryption technology will be putty in the hands of those running the post-quantum world. How equipped ...
Rocketship’s Anand Rajaraman on getting pitches from places like Rameswaram and Patna
Bengaluru-based Archeron group plans to open five banks that are run entirely by AI and quantum technologies
Ably skippered by N Srinivasan, India Cements is upping its post-Covid-19 game by expanding capacity
Three-in-one: Passive debt funds come at a low cost and have high-quality portfolios. Some offer return ...
Trend in the rupee movement and Q4 earnings can give direction to the market
There is room for improvement in fund transfer options
Silver looks positive but lacks the higher volumes required to substantiate bullishness
In an age of falling female workforce participation, worsened by the Covid-19 pandemic, policy makers and ...
Murder is a theme that is unlikely to darken and yellow with time, the writer Truman Capote had once said.
Expect the unexpected when musicians of different traditions come together for a duet
On Ugadi, the Telugu New Year Day, a chronicler recalls slices of an isolated year gone by and realises that ...
Marketers are padded up, sponsorship deals have been struck, and campaigns are rolling out. Now let the games ...
And what marketers can possibly do to bring it back in our lives
The agency has changed form over the years but its lustre has not dimmed
Media Factory has purchased the majority stake held by Sam and Lara Balsara of Madison World in Madison Media ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor